NZ594945A - Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof - Google Patents

Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Info

Publication number
NZ594945A
NZ594945A NZ594945A NZ59494507A NZ594945A NZ 594945 A NZ594945 A NZ 594945A NZ 594945 A NZ594945 A NZ 594945A NZ 59494507 A NZ59494507 A NZ 59494507A NZ 594945 A NZ594945 A NZ 594945A
Authority
NZ
New Zealand
Prior art keywords
staphylococcus aureus
activity against
killing activity
binding molecules
human binding
Prior art date
Application number
NZ594945A
Other languages
English (en)
Inventor
Kruif Cornelis Adriaan De
Mark Throsby
Robert A Kramer
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Priority to NZ606828A priority Critical patent/NZ606828A/en
Publication of NZ594945A publication Critical patent/NZ594945A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ594945A 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof NZ594945A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ606828A NZ606828A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US81154206P 2006-06-06 2006-06-06
EP06115013 2006-06-06
EP06116719 2006-07-06
EP06121258 2006-09-26
EP07103587 2007-03-06
NZ572775A NZ572775A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Publications (1)

Publication Number Publication Date
NZ594945A true NZ594945A (en) 2013-03-28

Family

ID=45220170

Family Applications (3)

Application Number Title Priority Date Filing Date
NZ606828A NZ606828A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
NZ594945A NZ594945A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
NZ572775A NZ572775A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ606828A NZ606828A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ572775A NZ572775A (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Country Status (5)

Country Link
KR (3) KR20180072676A (xx)
CN (1) CN102731651B (xx)
CA (1) CA2891316C (xx)
EA (1) EA021767B1 (xx)
NZ (3) NZ606828A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10738342B2 (en) * 2018-08-30 2020-08-11 Urinary Technologies, Inc. System for microbial species detection, quantification and antibiotic susceptibility identification
CN113493510A (zh) * 2021-07-07 2021-10-12 上海交通大学 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用
CN114196586B (zh) * 2021-12-20 2023-04-11 郑州大学 一株蒙氏肠球菌及其在发酵中草药中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6908994B1 (en) * 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
JP2005524624A (ja) * 2001-12-21 2005-08-18 バイオシネクサス インコーポレーテッド グラム陽性細菌のペプチドグリカンに対する多機能性モノクローナル抗体
JP2006502968A (ja) * 2002-02-21 2006-01-26 ユニヴエルシタ デリ スツディ ディ パヴィア 細菌性コラーゲン結合タンパク質に対して交差反応性のモノクロナール抗体

Also Published As

Publication number Publication date
CA2891316C (en) 2020-07-21
KR20180072676A (ko) 2018-06-29
KR20170042376A (ko) 2017-04-18
EA021767B1 (ru) 2015-08-31
CN102731651B (zh) 2015-02-04
KR20160003317A (ko) 2016-01-08
EA201200182A1 (ru) 2012-06-29
NZ606828A (en) 2014-08-29
NZ572775A (en) 2011-09-30
CA2891316A1 (en) 2007-12-13
CN102731651A (zh) 2012-10-17

Similar Documents

Publication Publication Date Title
NZ597046A (en) Use of alpha-toxin for treating and preventing staphylococcus infections
WO2005103084A3 (en) Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
MX2019007784A (es) Anticuerpos humanos a la toxina hemolisina a de s. aureus.
MX2019011117A (es) Anticuerpo b7-h3, fragmento de union a antigeno de los mismos y uso medico de los mismos.
MX337081B (es) Anticuerpo anti-nr10 y su uso.
NZ616921A (en) Gram-positive bacteria specific binding compounds
AU2006226733A8 (en) Antibodies against CD38 for treatment of multiple myeloma
WO2008076915A8 (en) Treatment of pigs with pcv2 antigen
UA100507C2 (ru) Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
MX2009004986A (es) Metodos de tratamiento de anemia hemolitica.
WO2008071418A3 (en) Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
PL2070530T3 (pl) Leczenie chorób związanych ze stosowaniem antybiotyków
EA201100413A1 (ru) Способ лечения бактериальной инфекции
CA2725873A1 (en) Monoclonal antibodies to basic fibroblast growth factor
BRPI0610722A2 (pt) métodos para tratar uma infecção bacteriana, para prevenir, tratar ou melhorar o tratamento eficaz de mrsa, para inibir o crescimento de um micróbio, e para selecionar um agente terapêutico de mrsa útil pata tratar uma infcção bacteriana, e, composição
WO2007133712A3 (en) Antimicrobial therapy for bacterial infections
WO2007056301A3 (en) Antibody therapy for treatment of diseases associated with gluten intolerance
WO2018027124A8 (en) ANTI-O2 ANTIBODIES AND USES THEREOF
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
NZ594945A (en) Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
WO2008097364A3 (en) Use of oritavancin for prevention and treatment of anthrax
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
WO2003103699A8 (en) USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS
WO2008033477A3 (en) Antimicrobial activity in variants of lacritin
TW200740845A (en) Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE MISSING INVENTOR HAS BEEN ADDED (1237706, THROSBY, MARK; 1248626, DE KRUIF, CORNELIS ADRIAAN; 3058645, KRAMER, ROBERT A, LOMBARDIJE 15, 3524 UTRECHT, NL)

Effective date: 20130215

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 JUN 2014 BY AJ PARK

Effective date: 20130808

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 JUN 2017 BY COMPUTER PACKAGES INC

Effective date: 20140628

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 JUN 2018 BY CPA GLOBAL

Effective date: 20170428

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 JUN 2019 BY CPA GLOBAL

Effective date: 20180503

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 JUN 2020 BY CPA GLOBAL

Effective date: 20190502

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 JUN 2021 BY CPA GLOBAL

Effective date: 20200430

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 JUN 2022 BY CPA GLOBAL

Effective date: 20210429

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 JUN 2023 BY CPA GLOBAL

Effective date: 20220428

LAPS Patent lapsed